Medpace Holdings, Inc. (MEDP): SEC Filings & AI Analysis
Healthcare. Latest 10-K, 10-Q, and 8-K filings for Medpace Holdings, Inc. (MEDP) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.
Most recent filing — 10-Q filed October 22, 2026: NEUTRAL Concern level: MODERATE.
Company overview — key questions
Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.
What is Medpace Holdings, Inc. (MEDP)?
Medpace Holdings, Inc. is a publicly traded company in the Healthcare space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.
What are MEDP's most recent SEC filings?
Recent filings: 10-Q (October 22, 2026), 8-K (October 21, 2026).
What does MEDP's latest filing analysis show?
MEDP's most recent 10-Q (October 22, 2026) is rated NEUTRAL, concern level MODERATE.
What is the 30-day outlook for MEDP?
Based on MEDP's latest filing, the model projects it will perform roughly in line with the S&P 500 over the next 30 days. This is model analysis for research, not investment advice.
Is MEDP a buy?
StockHuntr doesn't issue buy or sell ratings — it's a research tool. For Medpace Holdings, Inc. (MEDP), its latest 10-Q is rated MODERATE concern and the model projects it will perform roughly in line with the S&P 500 over 30 days. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.
Other Healthcare companies
About this analysis
- Primary source:
- View this company's filings on SEC EDGAR
- Additional data:
- Yahoo Finance (market data)
- Method:
- StockHuntr analyzes filings with AI — see our methodology.
- Analysis as of:
- October 22, 2026
- Published by:
- StockHuntr
For research and education only. Nothing here is investment advice.
Loading MEDP snapshot...
Fetching live market data